Redsense Medical presents at Stora AktiedagarnaStockholm

Stora Aktiedagarna in Stockholm, March 5-7, 2024, is a three-day event organized by Aktiespararna. During theses days, more than 50 large and small companies will be presenting. The event will be held at Birger Jarl Konferens in Stockholm.

Redsense Medical CEO Pontus Nobréus will present the company on March 5. The presentation will be held in Swedish.

For further information and registration to the event, please visit: https://www.aktiespararna.se/aktiviteter/stora-aktiedagarna-i-stockholm-44839

Contact information

For more information, please contact: 
Pontus Nobréus, CEO
Telephone: +46 72-171 1264
E-mail: pontus.nobreus (at) redsensemedical.com

Redsense Medical AB (publ), 556646-4862

ABOUT REDSENSE MEDICAL

Redsense Medical is a corporate group with operations mainly in Europe and the United States. The company has developed the Redsense System, an innovation used for monitoring and alarm in the case of blood leakage in connection with a hemodialysistreatment. Redsense Medical solves one of the most serious remaining safety problems within hemodialysis – to quickly detect Venous Needle Dislodgement and catheter leakage to minimize blood leakage. The system consists of a patented fiber optic sensor, designed for either venous needle or central venous catheter, which is connected to an alarm unit. From the very start, the development of the company's technology has been based on the demands and safety requirements of healthcare providers in the dialysis sector. The Redsense Medical share is listed on Spotlight Stock Market (REDS) and traded on OTCQX (RDSNF) in the US.